Simultaneous measurements of serum α-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma

American Journal of Gastroenterology

Volumn 95, Issue 4, 2000, Pages 1036-1040

  Ishii, Motoyasu ^a   Gama, Hiroko ^a   Chida, Nobuyuki ^a   Ueno, Yoshiyuki ^a   Shinzawa, Haruhide ^b   Takagi, Tooru ^c   Toyota, Takayoshi ^a   Takahashi, Tsuneo ^b   Kasukawa, Reiji ^c  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; VITAMIN K GROUP;

ARTICLE; CANCER DIAGNOSIS; CHRONIC HEPATITIS; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SERUM;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; PROTHROMBIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0034033231     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)00770-X     Document Type: Article

References (20)

1. Ebara M., Ohto M., Sugiura N., et al. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol. 5:1990;616-626.
2. Chen D.S., Sung J.L. Serum alphafetoprotein in hepatocellular carcinoma. Cancer. 40:1977;779-783.
3. Tsai S., Huang G., Yang P., et al. Plasma des-gamma-carboxyprotein in the early stage of hepatocellular carcinoma. Hepatology. 11:1990;481-488.
4. Ebara M., Ohto M., Shinagawa T., et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. Gastroenterology. 90:1986;289-298.
5. Oka H., Kuroki N., Kim K., et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology. 12:1990;680-687.
6. Takano S., Yokosuka O., Imazeki F., et al. Incidence of hepatocellular carcinoma in chronic hepatitis B and C A prospective study of 251 patients . Hepatology. 21:1995;650-655.
7. Baron R.L., Oliver J.H. III, Dodd G.D. III, et al. Hepatocellular carcinoma Evaluation with biphasic, contrast-enhanced helical CT . Radiology. 199:1996;505-511.
8. Edmondson H., Steiner P. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer. 7:1954;462-503.
9. Mita Y., Aoyagi Y., Yanagi M., et al. The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma. Cancer. 82:1998;1643-1648.
10. Nomura F., Ishijima M., Kuwa K., et al. Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma. Am J Gastroenterol. 94:1999;650-654.
11. Kasahara A., Hayashi N., Fusamoto H., et al. Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes. Dig Dis Sci. 38:1993;2170-2176.
12. Suehiro T., Matsumata T., Itasaka H., et al. Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma. Surgery. 117:1995;682-691.
13. Ono M., Ohta H., Ohhira M., et al. Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin and vitamin K in human liver tissues Overproduction of immunoreactive prothrombin in hepatocellular carcinoma . Am J Gastroenterol. 85:1990;1149-1154.
14. Aoyagi Y., Oguro M., Yanagi M., et al. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma. Cancer. 77:1996;1781-1786.
15. Izumi R., Shimizu K., Kiriyama M., et al. Alpha-fetoprotein production by hepatocellular carcinoma is prognostic of poor patient survival. J Surg Oncol. 49:1992;151-155.
16. Oka H., Tamori A., Kuroki T., et al. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology. 19:1994;61-66.
17. Suehiro T., Sugimachi K., Matsumata T., et al. Protein induced by vitamin K absence or antagonist as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein. Cancer. 73:1994;2462-2472.
18. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg. 211:1990;277-287.
19. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 354:1996;693-699.
20. Mor E., Kaspa R., Sheiner P., et al. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med. 129:1998;643-653.